Skip to main content
SpringerLink
Log in

Potential of Magnetic Resonance Spectroscopy for Radiotherapy Planning

  • Chapter
New Technologies in Radiation Oncology

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 3354 Accesses

10.4 Conclusion

MRSI has the potential to provide metabolic evidence of tumor activity that may be an important guide for therapeutic decisions. The treatment planning process and treatment planning systems should therefore have the ability to incorporate both metabolic and anatomic data in order to determine appropriate target volumes. Many problems need to be addressed and much work needs to be done in order to determine the optimal way to incorporate indices of metabolic activity, especially in light of newer treatment techniques such as IMRT; however, it is the present author’s belief that strong consideration should be given to the incorporation of functional imaging into the treatment process for focal or boost treatments for brain and prostate tumors. Given the discrepancies that have been found between MRI and MRSI determinants of target volumes, the results of controlled dose escalation studies for malignant tumors of the brain that have used MRI-derived target volumes should also be reevaluated given the possibility that these volumes may have been suboptimally defined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59:80–84

    PubMed  CAS  Google Scholar 

  • Bleehen NM, Stenning SP (1991) A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 64:769–774

    CAS  Google Scholar 

  • Burger PC, Heinz ER, Shibata T et al. (1988) Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698–704

    PubMed  CAS  Google Scholar 

  • Chamberlain MC, Barba D, Kormanik P et al. (1994) Stereotactic radiosurgery for recurrent gliomas. Cancer 74:1342–1347

    PubMed  CAS  Google Scholar 

  • Chan AA, Lau A, Pirzkall A et al. (2004) 1H-MRSI as a tool for evaluating grade IV glioma patients undergoing gamma knife radiosurgery. J Neurosurg 101:467–475

    PubMed  Google Scholar 

  • Chan JL, Lee SW, Fraass BA et al. (2002) Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20:1635–1642

    PubMed  Google Scholar 

  • Chuang C, Chan AA, Larson DL et al. (2004) Prognostic value of pre-Gamma Knife MR spectroscopic imaging for treatment strategy and clinical outcome. Int J Radiat Oncol Biol Phys (Abstract)

    Google Scholar 

  • Coakley FV, Teh BS, Quayyum A et al. (2004) Endorectal MR and MR spectroscopic imaging of locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233:441–448

    PubMed  Google Scholar 

  • Costello LC, Franklin RB (1991a) Concepts of citrate production and secretion by prostate. 1. Metabolic relationships. Prostate 18:25–46

    PubMed  CAS  Google Scholar 

  • Costello LC, Franklin RB (1991b) Concepts of citrate production and secretion by prostate. 2. Hormonal relationships in normal and neoplastic prostate. Prostate 19:181–205

    PubMed  CAS  Google Scholar 

  • Crook JM, Perry GA, Robertson S et al. (1995) Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology 45:624–631

    Article  PubMed  CAS  Google Scholar 

  • D’Amico AV, Schnall M, Whittington R et al. (1998) Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology 51:449–454

    PubMed  CAS  Google Scholar 

  • Esteve F, Rubin C, Grand S et al. (1998) Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 40:279–286

    PubMed  CAS  Google Scholar 

  • Fitzek MM, Thornton AF, Rabinov JD et al. (1999) Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 91:251–260

    PubMed  CAS  Google Scholar 

  • Garden AS, Maor MH, Yung WK et al. (1991) Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 20:99–110

    Article  PubMed  CAS  Google Scholar 

  • Graves EE, Nelson SJ, Vigneron DB et al. (2000) A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46:319–328

    PubMed  CAS  Google Scholar 

  • Graves EE, Pirzkall A, Nelson SJ et al. (2001) Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys 28:2489–2496

    PubMed  CAS  Google Scholar 

  • Gupta RK, Cloughesy TF, Sinha U et al. (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215–226

    Article  PubMed  CAS  Google Scholar 

  • Hall WA, Djalilian HR, Sperduto PW et al. (1995) Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13:1642–1648

    PubMed  CAS  Google Scholar 

  • Heston WD (1991) Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. Cancer Surv 11:217–238

    PubMed  CAS  Google Scholar 

  • Hirose M, Bharatha A, Hata N et al. (2002) Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy. Acad Radiol 9:906–912

    PubMed  Google Scholar 

  • Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907–911

    PubMed  CAS  Google Scholar 

  • Hricak H, White S, Vigneron D et al. (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal: pelvic phased-array coils. Radiology 193:703–709

    PubMed  CAS  Google Scholar 

  • Jung JA, Coakley FV, Quayyum A et al. (2004) Endorectal MR spectroscopi imaging of the prostate: investigation of a standardized evaluation system. Radiology 233:701–708

    PubMed  Google Scholar 

  • Kahn T, Burrig K, Schmitz-Drager B et al. (1989) Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 173:847–851

    PubMed  CAS  Google Scholar 

  • Kelly PJ, Daumas-Duport C, Kispert DB et al. (1987) Imagingbased stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865–874

    PubMed  CAS  Google Scholar 

  • Kurhanewicz J, Swanson MG, Nelson SJ et al. (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16:451–463

    Article  PubMed  Google Scholar 

  • Kurhanewicz J, Vigneron DB, Hricak H et al. (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution. Radiology 198:795–805

    PubMed  CAS  Google Scholar 

  • Kurhanewicz J, Vigneron DB, Nelson SJ (2000) Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2:166–189

    Article  PubMed  CAS  Google Scholar 

  • Larson DA, Gutin PH, McDermott M et al. (1996) Gamma knife for gliomas: selection factors and survival. Int J Radiat Oncol Biol Phys 36:1045–1053

    PubMed  CAS  Google Scholar 

  • Lee MC, Pirzkall A, McKnight TR et al. (2004) 1H-MRSI of radiation effects in normal-appearing white matter: dosedependence and impact on automated spectral classification. J Magn Reson Imaging 19:379–388

    Article  PubMed  Google Scholar 

  • Li X, Lu Y, Pirzkall A et al. (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229–237

    PubMed  Google Scholar 

  • Li X, Jin H, Lu Y et al. (2004) Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 17:10–20

    Article  PubMed  Google Scholar 

  • Liang BC, Thornton AF Jr, Sandler HM et al. (1991) Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 75:559–563

    PubMed  CAS  Google Scholar 

  • Maire JP, Coudin B, Guérin J et al. (1987) Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol 10:156–162

    PubMed  CAS  Google Scholar 

  • Marks JE, Baglan RJ, Prassad SC et al. (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7:243–252

    PubMed  CAS  Google Scholar 

  • McKnight TR, Noworolski SM, Vigneron DB et al. (2001) An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 13:167–177

    Article  PubMed  CAS  Google Scholar 

  • McKnight TR, Bussche MH von dem, Vigneron DB et al. (2002a) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794–802

    PubMed  Google Scholar 

  • McKnight TM, Vigneron DB, Love T et al. (2002b) Comparison of a Cho-NAA index with the MIB-1 proliferative index and cell density of tissue samples from grades II and III glioma. Proc 10th Scientific Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM), Honolulu, Hawaii, p 43

    Google Scholar 

  • Morris DE, Bourland JD, Rosenman JG et al. (2001) Three-dimensional conformal radiation treatment planning and delivery for low-and intermediate-grade gliomas. Semin Radiat Oncol 11:124–137

    PubMed  CAS  Google Scholar 

  • Nakagawa K, Aoki Y, Fujimaki T et al. (1998) High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:1141–1149

    Article  PubMed  CAS  Google Scholar 

  • Nelson SJ (2001) Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 46:228–239

    Article  PubMed  CAS  Google Scholar 

  • Nelson SJ, McKnight TR, Henry RG (2002a) Characterization of untreated gliomas by magnetic resonance spectroscopic imaging. Neuroimag Clin North Am 12:599–613

    Google Scholar 

  • Nelson SJ, Graves E, Pirzkall A et al. (2002b) In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 16:464–476

    Article  PubMed  Google Scholar 

  • Oh J, Henry RG, Pirzkall A et al. (2004) Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19:546–554

    Article  PubMed  Google Scholar 

  • Pickett B, Vigneault E, Kurhanewicz J et al. (1999) Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 44:921–929

    Article  PubMed  CAS  Google Scholar 

  • Pickett B, Pirzkall A, Kurhanewicz J et al. (2000) Radiosurgical intensity modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48:S23

    Article  Google Scholar 

  • Pickett B, Kurhanewicz J, Fein B et al. (2003) Use of magnetic resonance imaging and spectroscopy in the evaluation of external beam radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 57:S163–S164

    Article  Google Scholar 

  • Pickett B, TenHaken RK, Kurhanewicz J et al. (2004) Time course to metabolic atrophy following permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 59:665–673

    Article  PubMed  Google Scholar 

  • Pirzkall A (2005) Magnetic resonance spectroscopy and its use in brain tumor diagnosis and therapy. In: Black P, Loeffler JS (eds) Cancer of the nervous system, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, pp 109–122

    Google Scholar 

  • Pirzkall A, McKnight TR, Graves EE et al. (2001a) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915–928

    Article  PubMed  CAS  Google Scholar 

  • Pirzkall A, Graves EE, Lau A et al. (2001b) Gamma knife (GK) radiosurgery (RS) for recurrent high-grade gliomas: What does magnetic resonance spectroscopy have to add? Fifth International Stereotactic Radiosurgery Society Congress (ISRS), Las Vegas, Nevada, p 44

    Google Scholar 

  • Pirzkall A, Nelson SJ, McKnight TR et al. (2002) Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 53:1254–1264

    PubMed  Google Scholar 

  • Pirzkall A, Li X, Oh J et al. (2004) 3D MRSI for resected highgrade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 59:126–137

    Article  PubMed  Google Scholar 

  • Pollack A, Zagars GK (1997) External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 39:1011–1018

    PubMed  CAS  Google Scholar 

  • Pouliot J, Yongbok K, Lessard E et al. (2004) Inverse planning for HDR prostate brachytherapy use to boost dominant intraprostatic lesion defined by magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 59:1196–1207

    Article  PubMed  Google Scholar 

  • Roach M III, Faillace-Akazawa P, Malfatti C et al. (1996) Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35:1011–1018

    PubMed  Google Scholar 

  • Scheidler J, Hricak H, Vigneron DB et al. (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging: clinicopathologic study. Radiology 213:473–480

    PubMed  CAS  Google Scholar 

  • Schiebler ML, Tomaszewski JE, Bezzi M et al. (1989) Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 172:131–137

    PubMed  CAS  Google Scholar 

  • Schricker AA, Pauly JM, Kurhanewicz J et al. (2001) Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 46:1079–1087

    Article  PubMed  CAS  Google Scholar 

  • Shrieve DC, Alexander E III, Wen PY et al. (1995) Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275–282

    PubMed  CAS  Google Scholar 

  • Sijens PE, Vecht CJ, Levendag PC et al. (1995) Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. Invest Radiol 30:738–744

    PubMed  CAS  Google Scholar 

  • Sneed PK, Lamborn KR, Larson DA et al. (1996) Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 35:37–44

    Article  PubMed  CAS  Google Scholar 

  • Stamey TA, McNeal JE, Freiha FS et al. (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139:1235–1241

    PubMed  CAS  Google Scholar 

  • Swanson MG, Vigneron DB, Tabatabai ZL et al. (2003) Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 50:944–954

    Article  PubMed  CAS  Google Scholar 

  • Taylor JS, Langston JW, Reddick WE et al. (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251–1261

    PubMed  CAS  Google Scholar 

  • Teh BS, McGary JE, Dong L et al. (2002) The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: More than just a prostate gland immobilization device? Cancer J 8:476–483

    PubMed  Google Scholar 

  • Thilmann C, Zabel A, Grosser KH et al. (2001) Intensitymodulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer 96:341–349

    Article  PubMed  CAS  Google Scholar 

  • Tran TK, Vigneron DB, Sailasuta N et al. (2000) Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 43:23–33

    Article  PubMed  CAS  Google Scholar 

  • Vigneault E, Pouliot J, Laverdiere J et al. (1997) Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 37:205–212

    Article  PubMed  CAS  Google Scholar 

  • Vigneron DB, Males R, Hricak H et al. (1998) Prostate cancer: correlation of 3D MRSI metabolite levels with histologic grade. RSNA, Chicago, p 181

    Google Scholar 

  • Virta A, Patronas N, Raman R et al. (2000) Spectroscopic imaging of radiation-induced effects in the white matter of glioma patients. Magn Reson Imaging 18:851–857

    PubMed  CAS  Google Scholar 

  • Wald LL, Nelson SJ, Day MR et al. (1997) Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 87:525–534

    PubMed  CAS  Google Scholar 

  • Wallner KE, Galicich JH, Krol G et al. (1989) Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405–1409

    PubMed  CAS  Google Scholar 

  • Wefer AE, Hricak H, Vigneron DB et al. (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404

    Article  PubMed  CAS  Google Scholar 

  • Xia P, Pickett B, Vigneault E et al. (2001) Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. Int J Radiat Oncol Biol Phys 51:244–254

    PubMed  CAS  Google Scholar 

  • Yu KK, Scheidler J, Hricak H et al. (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488

    PubMed  CAS  Google Scholar 

  • Zaider M, Zelefsky MJ, Lee EK et al. (2000) Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 47:1085–1096

    Article  PubMed  CAS  Google Scholar 

  • Zakian KL, Eberhardt S, Hricak H et al. (2003) Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging: initial results. Radiology 229:241–247

    PubMed  Google Scholar 

  • Zelefsky MJ, Fuks Z, Hunt M et al. (2001) High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166:876–881

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Radiation Oncology,Radiology and Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, L-75, San Francisco, CA, 94143, USA

    Andrea Pirzkall MD (Assistant Adjunct Professor)

Authors
  1. Andrea Pirzkall MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Medizinische Physik in der Strahlentherapie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    Wolfgang Schlegel PhD (Professor) (Professor)

  2. Department of Radiation Oncology, Massachusetts General Hospital, 30,Fruit Street, Boston, MA, 02114, USA

    Thomas Bortfeld PhD (Professor) (Professor)

  3. Department of Radiation Oncology, Klinikum rechts der Isar Technical University Munich, Ismaningerstrasse 22, 81675, München, Germany

    Anca-Ligia Grosu MD (Privatdozent) (Privatdozent)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pirzkall, A. (2006). Potential of Magnetic Resonance Spectroscopy for Radiotherapy Planning. In: Schlegel, W., Bortfeld, T., Grosu, AL. (eds) New Technologies in Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29999-8_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-29999-8_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00321-2

  • Online ISBN: 978-3-540-29999-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation